Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human P2X ligand-gated ion channel 3 is a trimeric non-selective cation channel activated by extracellular ATP. It plays essential roles in nociceptive signaling within sensory neurons and represents an important therapeutic target for conditions involving chronic pain or hypersensitivity due to its unique structure-function properties—including rapid desensitization kinetics, divalent cation regulation of activation/desensitization cycles, and druggable allosteric sites amenable to small molecule inhibition.
Antagonism or allosteric modulation of P2X3 receptor, inhibiting ATP-mediated channel opening and reducing neuronal excitability
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on P2X Ligand-Gated Ion Channel 3 (P2X3 receptor).